GLP-1 Market
LLY $1240.34 ▼ -1.3% NVO $38.42 ▼ -1.1% PFE $29.44 ▼ -0.5% VKTX $25.05 ▼ -0.5% KLRA $11.43 ▲ +1.6% GPCR $22.01 ▲ +4.4% RHHBY $57.14 • 0.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Inhaled Technosphere Insulin

Company
Jaeb Center for Health Research
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for Inhaled Technosphere Insulin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06880835

    Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

    Not yet reported Jaeb Center for Health Research 30 participants Est. completion 2026-12-31 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00332826

    Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

    Not yet reported Mannkind Corporation 3 participants Est. completion 2007-10 78 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1, Asthma
    View official trial listing →
  • Completed NCT NCT00511602

    Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

    Not yet reported Mannkind Corporation 123 participants Est. completion 2005-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00511732

    18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

    Not yet reported Mannkind Corporation 227 participants Est. completion 2007-08
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00511979

    Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin

    Not yet reported Mannkind Corporation 12 participants Est. completion 2000-06
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00539396

    A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

    Not yet reported Mannkind Corporation 110 participants Est. completion 2005-12
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02470637

    Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

    Not yet reported Mannkind Corporation 30 participants Est. completion 2015-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02485327

    PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)

    Not yet reported Mannkind Corporation 22 participants Est. completion 2015-11 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT06535789

    Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

    Not yet reported, Not yet reported Jaeb Center for Health Research 30 participants Est. completion 2026-09-05 5 sites Stand-alone
    Other conditions: Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.